Investor Relations
Abcam IR Home
Share price & chart
Reports & accounts / Financial Calendar
Regulatory news (RNS)
Contacts & advisors
Governance
CSR statement
Directors
Major shareholders
Other Documents
The Abcam story
About research antibodies
Abcam company news
Main Abcam website

Full preliminary results for year 2005-6

Abcam has published preliminary results for the 12 months ended 30 June 2006.

Highlights include sales increased 60% to £19.4 million (2005: £12.1 million) and pre-tax profits increased 65% to 4.9 million (2005: £3.0 million). There has been continued expansion of Abcam's product range: 23,200 products available on the Abcam website at end June 2006, up 41% from 16,500 products at end June 2005.

This year has also showed continued geographic expansion with significant contribution in sales and profits in the year from the US office and a new office opened in Japan, the world’s third largest market for research antibodies.

You can download the full preliminary year results from our Key dates / Reports and accounts section.

---

back to news list